Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up

Purpose of reviewInitiatives are in place to reach super-fast targets by 2018 for paediatric patients living with HIV. However, these efforts are unlikely to be successful until better paediatric antiretrovirals and treatment strategies are available. This commentary reviews the specific features, c